SAN FRANCISCO, Nov. 13 – Pfizer joined Accelrys’ High Throughput Crystallography Consortium, Accelrys announced Tuesday.
Princeton, N.J.-based Accelrys, a subsidiary of Pharmacopeia, created the consortium to explore and validate rapid methods for X-ray structure determination, model building, and structure validation, according to the company. The agreement with Pfizer covers a number of sites, including Sandwich, UK, Groton, Ann Arbor and La Jolla.
With Pfizer, the consortium’s total membership is 13 companies, including Bristol-Myers Squibb, Genencor, and the Genetics Institute.